{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:08:29Z","timestamp":1760954909243},"reference-count":32,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.trim.2006.09.025","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T22:25:15Z","timestamp":1164839115000},"page":"227-231","source":"Crossref","is-referenced-by-count":3,"title":["sCD30, interleukin-1\u03b2-converting enzyme and anti-Annexin V autoantibodies concentrations in heart transplant recipients"],"prefix":"10.1016","volume":"16","author":[{"given":"S\u0142awomir","family":"\u017beglen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Zakliczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"No\u017cy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Rogala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Zembala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2006.09.025_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":"Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease","volume":"68","author":"Durkop","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.trim.2006.09.025_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/299065a0","article-title":"Production of monoclonal antibody specific for Hodgkin's and Reed-Sternberg cells of Hodgkin disease and a subset of normal lymphoid cells","volume":"299","author":"Schwab","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.trim.2006.09.025_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","article-title":"The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that the Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.09.025_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ijc.2910630524","article-title":"A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines","volume":"63","author":"Hansen","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trim.2006.09.025_bib5","first-page":"339","article-title":"Circulating levels of soluble CD30, a marker of cells producing Th2 type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity","volume":"13","author":"Caligaris","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trim.2006.09.025_bib6","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI119819","article-title":"Effects of subcutaneous interleukin 2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects","volume":"100","author":"De-Paoli","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2006.09.025_bib7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/jc.82.6.1757","article-title":"Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis","volume":"82","author":"Okumura","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trim.2006.09.025_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2222.1999.00450.x","article-title":"Soluble cytokine receptor CD30 in atopic disorders: a case\u2013control study","volume":"29","author":"Latza","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.trim.2006.09.025_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1373520","article-title":"Molecular cloning of the interleukin-1 beta converting enzyme","volume":"256","author":"Cerretti","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.trim.2006.09.025_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.trim.2006.09.025_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.trim.2006.09.025_bib12","doi-asserted-by":"crossref","first-page":"17907","DOI":"10.1074\/jbc.272.29.17907","article-title":"A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis","volume":"272","author":"Thornberry","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trim.2006.09.025_bib13","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1016\/S0021-9258(19)34062-1","article-title":"Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers","volume":"265","author":"Andree","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trim.2006.09.025_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00002281-200009000-00004","article-title":"Update on antiphospholipid antibodies","volume":"12","author":"Roubey","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trim.2006.09.025_bib15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"148","author":"Fadok","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2006.09.025_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<209::AID-AJH6>3.0.CO;2-#","article-title":"Clinical significance of anti-Annexin V antibodies in patients with systemic lupus erythematosus","volume":"54","author":"Kaburaki","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trim.2006.09.025_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/298H-NLBU-E47G-8PYL","article-title":"Elevated anti-Annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities","volume":"114","author":"Ogawa","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trim.2006.09.025_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s000180050067","article-title":"Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis","volume":"53","author":"Reutelingsperger","year":"1997","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trim.2006.09.025_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.55.12.895","article-title":"Annexin V autoantibodies in rheumatoid arthritis","volume":"55","author":"Rodriguez-Garcia","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trim.2006.09.025_bib20","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.trim.2006.09.025_bib21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1152\/ajpheart.00025.2003","article-title":"Clinical implications of apoptosis in hypertensive heart disease","volume":"284","author":"Fortuno","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trim.2006.09.025_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.RES.81.2.137","article-title":"Death by design. Programmed cell death in cardiovascular biology and disease","volume":"81","author":"MacLellan","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.trim.2006.09.025_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/CS20040086","article-title":"Role of apoptosis in atherosclerosis and its therapeutic implications","volume":"107","author":"Stoneman","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.trim.2006.09.025_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/jmcc.1999.1057","article-title":"Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes","volume":"32","author":"de Moissac","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trim.2006.09.025_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(00)81334-3","article-title":"Human ICE\/CED-3 protease nomenclature","volume":"87","author":"Alnemri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.trim.2006.09.025_bib26","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1074\/jbc.271.9.4573","article-title":"Molecular ordering of the cell death pathway: Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases","volume":"271","author":"Chinnaiyan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trim.2006.09.025_bib27","doi-asserted-by":"crossref","first-page":"24785","DOI":"10.1074\/jbc.M400985200","article-title":"Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity","volume":"279","author":"Lamkanfi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trim.2006.09.025_bib28","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1152\/ajpheart.2001.280.5.H2313","article-title":"Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I\/R injury in transgenic mice","volume":"280","author":"Chen","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trim.2006.09.025_bib29","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0002-9149(97)00228-2","article-title":"Serum levels of soluble form of Fas molecule in patients with congestive heart failure","volume":"15","author":"Okuyama","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.trim.2006.09.025_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway","volume":"163","author":"Chiarle","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2006.09.025_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/01.TP.0000085286.93715.E0","article-title":"Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30","volume":"76","author":"Susal","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.09.025_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.TP.0000044702.18327.66","article-title":"Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection","volume":"75","author":"Pelzl","year":"2003","journal-title":"Transplantation"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632740600133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632740600133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T21:23:10Z","timestamp":1683667390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632740600133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":32,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S096632740600133X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2006.09.025","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}